- Investing Ideas
- South Korean Pharmaceuticals & Biotech Undervalued based on future growth
South Korean Pharmaceuticals & Biotech Undervalued based on future growth
Results
1
0 new
Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)
1 companies